LegitScript.com has requested that GoDaddy terminate 155 steroid websites that they have determined are responsible for selling anabolic steroids over the internet to U.S. residents. LegitScript.com sent the termination request via email and via U.S. mail on July 1, 2008. LegitScript.com argues that domain registrars have a legal, social and moral obligation to shutdown the steroid websites they identified because they violate the registrar’s terms of service Read more
The Drug Enforcement Agency (DEA) is pushing for easier online access to anabolic steroids and other scheduled drugs. Physicians will soon be able to digitally prescribe steroids to patients. While it is generally agreed that this is a good move to reduce medical mistakes, some drug law policy experts feel it will make the DEA’s job more difficult.
Why, then, is the DEA pushing for easier online access to these drugs? And who is lobbying the DEA to do this, when it clearly will only make the DEA’s job harder?
When it comes to policy matters, it is always helpful to follow the money trail to understand the actions of federal agencies and bureacrats. Pharmaceutical companies (Barr Pharmaceuticals), large employers (Wal-mart), prescribing software makers (Allscripts Healthcare Solutions) and electronic prescription networks have lobbied for and/or supported the electronic prescribing of controlled substances. Read more
